A Novel Radiomics Nomogram for the Prediction of Secondary Loss of Response to Infliximab in Crohn’s Disease

PURPOSE: The prediction of the loss of response (LOR) to infliximab (IFX) is crucial for optimizing treatment strategies and shifting biologics. However, a secondary LOR is difficult to predict by endoscopy due to the intestinal stricture, perforation, and fistulas. This study aimed to develop and v...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yueying, Li, Hanyang, Feng, Jing, Suo, Shiteng, Feng, Qi, Shen, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238542/
https://www.ncbi.nlm.nih.gov/pubmed/34194236
http://dx.doi.org/10.2147/JIR.S314912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238542/
https://www.ncbi.nlm.nih.gov/pubmed/34194236
http://dx.doi.org/10.2147/JIR.S314912

Ejemplares similares